{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:17:58Z","timestamp":1792685878636,"version":"4.5.0"},"reference-count":307,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcp.2024.116137","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:14:15Z","timestamp":1710504855000},"page":"116137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Adipose tissue in cortisol excess: What Cushing\u2019s syndrome can teach us?"],"prefix":"10.1016","volume":"223","author":[{"given":"Alessandro","family":"Bavaresco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lazzara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-5727","authenticated-orcid":false,"given":"Mattia","family":"Barbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116137_b0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-19-0305","article-title":"Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark","volume":"181","author":"Laugesen","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0010","doi-asserted-by":"crossref","unstructured":"Lindholm, J. et al. Incidence and Late Prognosis of Cushing\u2019s Syndrome: A Population-Based Study. 86, (2001).","DOI":"10.1210\/jc.86.1.117"},{"key":"10.1016\/j.bcp.2024.116137_b0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11102-014-0569-6","article-title":"Incidence of Cushing\u2019s syndrome and Cushing\u2019s disease in commercially-insured patients <65 years old in the United States","volume":"18","author":"Broder","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.bcp.2024.116137_b0020","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/jama.2023.5444","article-title":"Diagnosis and Management of Pituitary Adenomas: a review","volume":"329","author":"Tritos","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2024.116137_b0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11154-010-9139-z","article-title":"The ectopic ACTH syndrome","volume":"11","author":"Alexandraki","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bcp.2024.116137_b0030","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2009-0612","article-title":"Approach to the patient with possible Cushing\u2019s syndrome","volume":"94","author":"Boscaro","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101380","article-title":"Cushing\u2019s syndrome: overview of clinical presentation, diagnostic tools and complications","volume":"34","author":"Barbot","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0040","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical Practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing\u2019s disease over 50 Years in stoke-on-Trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/ijms22020623","article-title":"Molecular mechanisms of glucocorticoid-induced insulin resistance","volume":"22","author":"Beaupere","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116137_b0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000314272","article-title":"Metabolic syndrome in Cushing\u2019s syndrome","volume":"92","author":"Chanson","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0060","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/DMSO.S247379","article-title":"Glucocorticoid-induced fatty liver disease","volume":"13","author":"Rahimi","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.bcp.2024.116137_b0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0960-0760(92)90220-D","article-title":"Tissue localization of 11\u03b2-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor","volume":"41","author":"Whorwood","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2024.116137_b0070","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2024.116137_b0075","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1210\/jc.2002-030017","article-title":"Subcutaneous adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima indians and caucasians","volume":"88","author":"Lindsay","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0080","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1210\/endo.140.7.6868","article-title":"Differentiation of adipose stromal cells: the roles of glucocorticoids and 11\u03b2-hydroxysteroid Dehydrogenase*","volume":"140","author":"Bujalska","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0085","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1210\/jc.2004-0153","article-title":"Overexpression of 11\u03b2-hydroxysteroid Dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins","volume":"89","author":"Kannisto","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0090","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(96)11222-8","article-title":"Does central obesity reflect \u201cCushing\u2019s disease of the omentum\u201d?","volume":"349","author":"Bujalska","year":"1997","journal-title":"The Lancet"},{"key":"10.1016\/j.bcp.2024.116137_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/oby.2004.3","article-title":"Regulation of 11\u03b2-HSD genes in human adipose tissue: influence of central obesity and weight loss","volume":"12","author":"Engeli","year":"2004","journal-title":"Obes. Res."},{"key":"10.1016\/j.bcp.2024.116137_b0100","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/oby.2007.618","article-title":"Omental 11\u03b2-hydroxysteroid dehydrogenase 1 Correlates with fat cell size independently of Obesity*","volume":"15","author":"Michailidou","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.bcp.2024.116137_b0105","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1210\/jc.2008-2011","article-title":"Omental adipose tissue type 1 11\u03b2-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women","volume":"94","author":"Veilleux","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0110","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/oby.2008.207","article-title":"Depot-specific regulation of the conversion of Cortisone to Cortisol in human adipose tissue","volume":"16","author":"Lee","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.bcp.2024.116137_b0115","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116137_b0120","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116137_b0125","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1074\/jbc.M103676200","article-title":"Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11\u03b2-hydroxysteroid dehydrogenase type 1 null mice","volume":"276","author":"Morton","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116137_b0130","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","article-title":"Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11\u03b2-hydroxysteroid dehydrogenase type 1\u2013Deficient mice","volume":"53","author":"Morton","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b0135","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1530\/EJE-15-1237","article-title":"MECHANISMS IN ENDOCRINOLOGY: tissue-specific activation of cortisol in Cushing\u2019s syndrome","volume":"175","author":"Morgan","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1323681111","article-title":"11\u03b2-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess","volume":"111","author":"Morgan","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116137_b0145","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/dom.12317","article-title":"Safety, efficacy and weight effect of two 11\u03b2- HSD1 inhibitors in metformin-treated patients with type 2 diabetes","volume":"16","author":"Heise","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0150","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11-\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2024.116137_b0155","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1463-1326.2011.01375.x","article-title":"Effects of an 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome","volume":"13","author":"Feig","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jash.2011.01.009","article-title":"Efficacy and safety of the selective 11\u03b2-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension","volume":"5","author":"Shah","year":"2011","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.bcp.2024.116137_b0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/clinem\/dgaa766","article-title":"11\u03b2HSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic Intracranial hypertension","volume":"106","author":"Hardy","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/eje.1.02228","article-title":"Adipose tissue 11\u03b2-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing\u2019s syndrome","volume":"155","author":"Mariniello","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0175","first-page":"57","article-title":"Absence of cushingoid phenotype in a patient with Cushing\u2019s disease due to defective Cortisone to Cortisol conversion","volume":"87","author":"Tomlinson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0180","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1507\/endocrj.K08E-008","article-title":"A case of Cortisol producing adrenal adenoma without phenotype of Cushing\u2019s syndrome due to impaired 11.BETA.-hydroxysteroid dehydrogenase 1 activity","volume":"55","author":"Arai","year":"2008","journal-title":"Endocr. J."},{"key":"10.1016\/j.bcp.2024.116137_b0185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0190","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common Carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1 Year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0195","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing\u2019s syndrome of different aetiologies during active disease and 1 year after remission: Cushing\u2019s syndrome and metabolic\/cardiovascular outcomes","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0200","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cen.12431","article-title":"Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing\u2019s disease: results from a phase III study","volume":"81","author":"Pivonello","year":"2014","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000314294","article-title":"Management of Dyslipidemia in Cushing\u2019s syndrome","volume":"92","author":"Greenman","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0026-0495(91)90189-4","article-title":"Hypolipidemic effect and mechanism of ketoconazole without and with cholestyramine in familial hypercholesterolemia","volume":"40","author":"Gylling","year":"1991","journal-title":"Metabolism."},{"key":"10.1016\/j.bcp.2024.116137_b0215","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11102-022-01263-7","article-title":"Levoketoconazole in the treatment of patients with endogenous Cushing\u2019s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)","volume":"25","author":"Pivonello","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.bcp.2024.116137_b0220","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing\u2019s disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0225","first-page":"26","article-title":"Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing\u2019s syndrome","volume":"67","author":"Moncet","year":"2007","journal-title":"Medicina (mex.)"},{"key":"10.1016\/j.bcp.2024.116137_b0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-07-0514","article-title":"Ketoconazole revisited: a preoperative or postoperative treatment in Cushing\u2019s disease","volume":"158","author":"Castinetti","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0235","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.1991.tb03547.x","article-title":"Ketoconazole treatment in Cushing\u2019s syndrome: experience in 34 patients","volume":"35","author":"Sonino","year":"1991","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0240","doi-asserted-by":"crossref","first-page":"A515","DOI":"10.1210\/jendso\/bvab048.1053","article-title":"Metyrapone treatment in endogenous Cushing\u2019s syndrome: results at week 12 from PROMPT, a prospective international multicenter, open-label, phase III\/IV study","volume":"5","author":"Nieman","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.bcp.2024.116137_b0245","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12020-018-1675-4","article-title":"Metyrapone treatment in Cushing\u2019s syndrome: a real-life study","volume":"62","author":"Ceccato","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.bcp.2024.116137_b0250","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2012.04424.x","article-title":"A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing\u2019s syndrome","volume":"77","author":"Valassi","year":"2012","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.2.6081.215","article-title":"Metyrapone in long-term management of Cushing\u2019s disease","volume":"2","author":"Jeffcoate","year":"1977","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bcp.2024.116137_b0260","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","article-title":"Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing\u2019s syndrome","volume":"35","author":"Verhelst","year":"1991","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0265","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing\u2019s disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0270","doi-asserted-by":"crossref","first-page":"1236465","DOI":"10.3389\/fendo.2023.1236465","article-title":"Long-term efficacy and safety of osilodrostat in patients with Cushing\u2019s disease: results from the LINC 4 study extension","volume":"14","author":"Gadelha","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0275","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3390\/biomedicines11123227","article-title":"Cushing\u2019s disease: long-term effectiveness and safety of osilodrostat in a polish Group of Patients with persistent Hypercortisolemia in the Experience of a single center","volume":"11","author":"Dzialach","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2024.116137_b0280","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1210\/clinem\/dgac691","article-title":"Efficacy and safety of osilodrostat in Paraneoplastic Cushing syndrome: a real-world multicenter study in France","volume":"108","author":"Dormoy","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0285","first-page":"671","article-title":"Possible mechanism and treatment of o, p\u2019DDD-induced hypercholesterolaemia","volume":"84","author":"Maher","year":"1992","journal-title":"Q. J. Med."},{"key":"10.1016\/j.bcp.2024.116137_b0290","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM197903013000903","article-title":"Treatment of Cushing\u2019s disease by O, p\u2019DDD. survey of 62 cases","volume":"300","author":"Luton","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116137_b0295","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-92-5-613","article-title":"Sustained remission of Cushing\u2019s disease with mitotane and Pituitary irradiation","volume":"92","author":"Schteingart","year":"1980","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcp.2024.116137_b0300","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","article-title":"Efficiency and tolerance of mitotane in Cushing\u2019s disease in 76 patients from a single center","volume":"167","author":"Baudry","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/js.2018-00269","article-title":"Continuous etomidate infusion for the Management of Severe Cushing Syndrome: validation of a Standard protocol","volume":"3","author":"Carroll","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.bcp.2024.116137_b0310","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0315","doi-asserted-by":"crossref","first-page":"e60984","DOI":"10.1371\/journal.pone.0060984","article-title":"Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of Cortisol: a pilot study","volume":"8","author":"Debono","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bcp.2024.116137_b0320","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.2337\/dc13-0246","article-title":"Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: Early and late effects","volume":"36","author":"Wallia","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2024.116137_b0325","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing\u2019s syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0330","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12020-018-1818-7","article-title":"The medical treatment with pasireotide in Cushing\u2019s disease: an italian multicentre experience based on \u201creal-world evidence\u201d","volume":"64","author":"Pivonello","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.bcp.2024.116137_b0335","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.662865","article-title":"Relacorilant, a selective glucocorticoid receptor modulator, induces clinical improvements in patients with Cushing syndrome: results from a prospective, open-label phase 2 study","volume":"12","author":"Pivonello","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0340","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing\u2019s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0345","doi-asserted-by":"crossref","first-page":"e4818","DOI":"10.1097\/MD.0000000000004818","article-title":"Effects of cabergoline on blood glucose levels in type 2 diabetic patients","volume":"95","author":"Bahar","year":"2016","journal-title":"Medicine (baltimore)"},{"key":"10.1016\/j.bcp.2024.116137_b0350","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/me.2008-0464","article-title":"Direct effect of glucocorticoids on lipolysis in adipocytes","volume":"23","author":"Xu","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0355","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2006.02488.x","article-title":"Characterization of the metabolic phenotypes of Cushing\u2019s syndrome and growth hormone deficiency: a study of body composition and energy metabolism","volume":"64","author":"Burt","year":"2006","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0360","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1055\/a-1547-9008","article-title":"CT-based abdominal adipose tissue area changes in patients undergoing adrenalectomy due to Cushing\u2019s syndrome and non-functioning adenomas","volume":"130","author":"G\u00fcndo\u011fdu","year":"2022","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b0365","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13143","article-title":"Glucose and lipid metabolism abnormalities in C ushing\u2019s syndrome","volume":"34","author":"Salehidoost","year":"2022","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0370","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2007.10.004","article-title":"Developmental origin of fat: Tracking obesity to its source","volume":"131","author":"Gesta","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2024.116137_b0375","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.1998.tb08325.x","article-title":"Brown adipose tissue: more than an effector of thermogenesis? a","volume":"856","author":"Cannon","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116137_b0380","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/EJE-21-0553","article-title":"MECHANISMS IN ENDOCRINOLOGY: local and systemic effects of glucocorticoids on metabolism: new lessons from animal models","volume":"185","author":"Swarbrick","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0385","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2016.06.011","article-title":"Glucocorticoids acutely increase Brown adipose tissue activity in humans, revealing species-specific differences in UCP-1 regulation","volume":"24","author":"Ramage","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0390","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2024.116137_b0395","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","article-title":"Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human","volume":"150","author":"Wu","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2024.116137_b0400","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of Brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116137_b0405","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1190816","article-title":"Beige can be slimming","volume":"328","author":"Ishibashi","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116137_b0410","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1074\/jbc.M109.053942","article-title":"Chronic Peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes Molecularly distinct from classic Brown adipocytes","volume":"285","author":"Petrovic","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116137_b0415","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1210\/en.2011-1349","article-title":"Inducible Brown adipogenesis of Supraclavicular fat in adult humans","volume":"152","author":"Lee","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0420","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature11943","article-title":"Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat","volume":"495","author":"Schulz","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116137_b0425","first-page":"969","article-title":"Pharmacological and nutritional agents promoting browning of white adipose tissue","volume":"1831","author":"Bonet","year":"2013","journal-title":"Biochim. Biophys. Acta BBA \u2013 Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bcp.2024.116137_b0430","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1101\/gad.211649.112","article-title":"Adaptive thermogenesis in adipocytes: is beige the new brown?","volume":"27","author":"Wu","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2024.116137_b0435","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biochi.2017.01.007","article-title":"UCP1 in adipose tissues: two steps to full browning","volume":"134","author":"Kalinovich","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2024.116137_b0440","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/joe.0.1640331","article-title":"Modulation of uncoupling protein 2 and uncoupling protein 3: regulation by denervation, leptin and retinoic acid treatment","volume":"164","author":"Scarpace","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0445","doi-asserted-by":"crossref","first-page":"R1209","DOI":"10.1152\/ajpregu.1995.268.5.R1209","article-title":"Glucocorticoids and insulin: complex interaction on brown adipose tissue","volume":"268","author":"Strack","year":"1995","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bcp.2024.116137_b0450","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1152\/ajpendo.1988.255.2.E153","article-title":"Glucocorticoids modulate beta-adrenoceptor subtypes and adenylate cyclase in brown fat","volume":"255","author":"Scarpace","year":"1988","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0455","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0303-7207(02)00027-8","article-title":"Opposing effects of glucocorticoids on \u03b23-adrenergic receptor expression in HIB-1B brown adipocytes","volume":"190","author":"Bakopanos","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0460","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yfrne.2004.07.001","article-title":"Cortisol pulsatility and its role in stress regulation and health","volume":"25","author":"Young","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0465","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/JOE-14-0538","article-title":"Effects of glucocorticoids on human brown adipocytes","volume":"224","author":"Barclay","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0470","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2967\/jnumed.116.186460","article-title":"Dissociation between Brown adipose tissue 18 F-FDG uptake and thermogenesis in uncoupling protein 1\u2013Deficient mice","volume":"58","author":"Hankir","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bcp.2024.116137_b0475","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.molmet.2017.02.006","article-title":"\u03b2 3 -adrenergically induced glucose uptake in brown adipose tissue is independent of UCP1 presence or activity: mediation through the mTOR pathway","volume":"6","author":"Olsen","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0480","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1210\/jc.2012-3535","article-title":"Presence of Brown adipocytes in Retroperitoneal fat from patients with benign adrenal tumors: relationship with outdoor temperature","volume":"98","author":"Betz","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0485","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/dom.13157","article-title":"Glucocorticoids suppress brown adipose tissue function in humans: a double-blind placebo-controlled study","volume":"20","author":"Thuzar","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0490","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.metabol.2017.01.024","article-title":"Glucocorticoids modulate human brown adipose tissue thermogenesis in vivo","volume":"70","author":"Scotney","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2024.116137_b0495","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-2275(20)41151-4","article-title":"Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes","volume":"35","author":"Slavin","year":"1994","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116137_b0500","doi-asserted-by":"crossref","first-page":"C198","DOI":"10.1152\/ajpcell.00045.2010","article-title":"Adipogenic and lipolytic effects of chronic glucocorticoid exposure","volume":"300","author":"Campbell","year":"2011","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"10.1016\/j.bcp.2024.116137_b0505","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0026-0495(71)90086-2","article-title":"Relationship of protein synthesis and cyclic AMP to lipolytic action of growth hormone and glucocorticoids","volume":"20","author":"Fain","year":"1971","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2024.116137_b0510","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/0026-0495(91)90078-B","article-title":"Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2","volume":"40","author":"Richelsen","year":"1991","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2024.116137_b0515","doi-asserted-by":"crossref","first-page":"32097","DOI":"10.1074\/jbc.M109.002675","article-title":"Spatiotemporal regulation of Early lipolytic signaling in adipocytes","volume":"284","author":"Martin","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116137_b0520","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1194\/jlr.M900176-JLR200","article-title":"Functional interaction of hormone-sensitive lipase and perilipin in lipolysis","volume":"50","author":"Shen","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116137_b0525","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1194\/jlr.R800031-JLR200","article-title":"Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores","volume":"50","author":"Zechner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116137_b0530","doi-asserted-by":"crossref","first-page":"40236","DOI":"10.1074\/jbc.M608048200","article-title":"Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue Triacylglycerol catabolism","volume":"281","author":"Schweiger","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116137_b0535","first-page":"799","article-title":"Effects of Cortisol and growth hormone on lipolysis in human adipose tissue 1","volume":"85","author":"Ottosson","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0540","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.abb.2008.02.034","article-title":"Insulin action and signalling in fat and muscle from dexamethasone-treated rats","volume":"474","author":"Bur\u00e9n","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2024.116137_b0545","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0026-0495(75)90035-9","article-title":"The mechanism of the potentiating effect of glucocorticoids on catecholamine-induced lipolysis","volume":"24","author":"Lamberts","year":"1975","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2024.116137_b0550","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2265.1994.tb01831.x","article-title":"Inhibition of growth hormone release after the combined administration of CHRH and GHRP-6 in patients with Cushing\u2019s syndrome","volume":"41","author":"Leal-Cerro","year":"1994","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0555","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11102-013-0528-7","article-title":"GH secretion reserve in subclinical hypercortisolism","volume":"17","author":"Palmieri","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.bcp.2024.116137_b0560","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2024.116137_b0565","doi-asserted-by":"crossref","first-page":"582","DOI":"10.20945\/2359-3997000000188","article-title":"Insulin signaling in the whole spectrum of GH deficiency","volume":"63","author":"Garmes","year":"2020","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0570","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI114345","article-title":"Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium","volume":"84","author":"Hauner","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b0575","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1101\/gad.1907110","article-title":"Propagation of adipogenic signals through an epigenomic transition state","volume":"24","author":"Steger","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2024.116137_b0580","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2013.05.020","article-title":"Human but not mouse adipogenesis is critically dependent on LMO3","volume":"18","author":"Lindroos","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0585","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/HYPERTENSIONAHA.114.04981","article-title":"Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase","volume":"66","author":"Urbanet","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2024.116137_b0590","doi-asserted-by":"crossref","first-page":"bqz010","DOI":"10.1210\/endocr\/bqz010","article-title":"Role of mineralocorticoid receptor in adipogenesis and obesity in male mice","volume":"161","author":"Ferguson","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0595","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/ijms18051032","article-title":"Aldosterone and mineralocorticoid receptors\u2014Physiology and pathophysiology","volume":"18","author":"Funder","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116137_b0600","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jcem-67-6-1122","article-title":"Muscle and adipose tissue morphology and metabolism in Cushing\u2019s Syndrome*","volume":"67","author":"Rebuff\u00e9-Scrive","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0605","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1096\/fj.07-094144","article-title":"AMP-activated protein kinase mediates glucocorticoid- induced metabolic changes: a novel mechanism in Cushing\u2019s syndrome","volume":"22","author":"Christ-Crain","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2024.116137_b0610","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1210\/jc.2008-1297","article-title":"Changes in adenosine 5\u2032-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing\u2019s syndrome","volume":"93","author":"Kola","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0615","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/ijms17010124","article-title":"Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules","volume":"17","author":"Moseti","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116137_b0620","unstructured":"Chen, S., Li, Z., Li, W., Shan, Z. & Zhu, W. Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK. 89, (2011)."},{"key":"10.1016\/j.bcp.2024.116137_b0625","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0020-711X(85)90151-X","article-title":"The stimulation of lipogenesis in white adipose tissue from fed rats by corticosterone","volume":"17","author":"Minshull","year":"1985","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.bcp.2024.116137_b0630","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0005-2760(75)90113-7","article-title":"Hormonal regulation of fatty acid synthetase, acetyl-CoA carboxylase and fatty acid synthesis in mammalian adipose tissue and liver","volume":"380","author":"Volpe","year":"1975","journal-title":"Biochim. Biophys. Acta BBA - Lipids Lipid Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0635","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/bj1030627","article-title":"Effect of glucocorticoid hormones on fatty acid mobilization and re-esterification in rat adipose tissue","volume":"103","author":"Jeanrenaud","year":"1967","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116137_b0640","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/bj3050065","article-title":"Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells: opposite effects of dexamethasone and isoprenaline on transcription","volume":"305","author":"Franckhauser","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116137_b0645","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00284","article-title":"Diabetes Mellitus Secondary to Cushing\u2019s Disease","volume":"9","author":"Barbot","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0650","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing\u2019s syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0655","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.2337\/diabetes.49.10.1700","article-title":"Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction","volume":"49","author":"Sakoda","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b0660","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1210\/jc.2003-031157","article-title":"Glucocorticoids Down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes","volume":"89","author":"Lundgren","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0665","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1\u2013PGC-1\u03b1 interaction","volume":"423","author":"Puigserver","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116137_b0670","author":"Ferra\u00f9","year":"2018","journal-title":"Metabolic Syndrome in Cushing\u2019s Syndrome Patients."},{"key":"10.1016\/j.bcp.2024.116137_b0675","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2362.2002.00993.x","article-title":"Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle","volume":"32","author":"L\u00f6fberg","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b0680","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diab.44.4.441","article-title":"Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli","volume":"44","author":"Weinstein","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b0685","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00125-005-1886-0","article-title":"Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor","volume":"48","author":"Ruzzin","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2024.116137_b0690","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2014.06.001","article-title":"FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in mice","volume":"393","author":"Feng","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0695","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/jn\/134.5.1032","article-title":"The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue","volume":"134","author":"Wang","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.bcp.2024.116137_b0700","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2337\/db17-1577","article-title":"Adipocyte glucocorticoid receptor deficiency promotes adipose tissue expandability and improves the metabolic profile under corticosterone exposure","volume":"68","author":"Dalle","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b0705","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1074\/jbc.272.6.3216","article-title":"Dexamethasone induces Posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic \u03b2 cells: COMPARISON WITH THE EFFECTS OF FATTY ACIDS *","volume":"272","author":"Gremlich","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116137_b0710","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0030-1269896","article-title":"Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats","volume":"43","author":"Rafacho","year":"2011","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bcp.2024.116137_b0715","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/db17-1314","article-title":"Adaptive \u03b2-cell neogenesis in the adult mouse in response to glucocorticoid-induced insulin resistance","volume":"68","author":"Courty","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b0720","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI107473","article-title":"Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man","volume":"52","author":"Wise","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b0725","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1262-3636(07)70123-4","article-title":"Dexamethasone-induced insulin resistance shows no gender difference in healthy humans","volume":"30","author":"Binnert","year":"2004","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0730","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00125-013-3016-8","article-title":"Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial","volume":"56","author":"van Raalte","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2024.116137_b0735","doi-asserted-by":"crossref","first-page":"e13114","DOI":"10.1111\/jne.13114","article-title":"Clinical presentation and etiology of Cushing\u2019s syndrome: data from ERCUSYN","volume":"34","author":"Valassi","year":"2022","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0740","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11154-019-09536-6","article-title":"The pathogenic role of the GIP\/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes","volume":"21","author":"Regazzo","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bcp.2024.116137_b0745","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00125-012-2459-7","article-title":"Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes","volume":"55","author":"Jensen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2024.116137_b0750","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00125-015-3522-y","article-title":"Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance","volume":"58","author":"Eriksen","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2024.116137_b0755","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.3390\/ijms23095217","article-title":"Incretin response to mixed meal challenge in active Cushing\u2019s disease and after pasireotide therapy","volume":"23","author":"Barbot","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116137_b0760","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/ccr3.3230","article-title":"Pasireotide-induced hyperglycemia in a patient with Cushing\u2019s disease: potential use of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist for treatment","volume":"8","author":"Shikata","year":"2020","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.bcp.2024.116137_b0765","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1210\/endo.140.9.7001","article-title":"Starvation: Early signals, sensors, and sequelae 1","volume":"140","author":"Dallman","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0770","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1152\/ajpregu.1995.268.1.R142","article-title":"Glucocorticoids and insulin: reciprocal signals for energy balance","volume":"268","author":"Strack","year":"1995","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bcp.2024.116137_b0775","doi-asserted-by":"crossref","first-page":"E317","DOI":"10.1152\/ajpendo.1996.271.2.E317","article-title":"Effects of glucocorticoids on energy metabolism and food intake in humans","volume":"271","author":"Tataranni","year":"1996","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0780","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00421-008-0904-6","article-title":"Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men","volume":"105","author":"Rieth","year":"2009","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.bcp.2024.116137_b0785","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2796.2003.01099.x","article-title":"Effects of glucocorticoids on leptin levels and eating behaviour in women","volume":"253","author":"Udd\u00e9n","year":"2003","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bcp.2024.116137_b0790","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0361-9230(91)90136-8","article-title":"Glucocorticoids as modulators in the control of feeding","volume":"27","author":"Castonguay","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bcp.2024.116137_b0795","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11102-015-0690-1","article-title":"A prospective study of appetite and food craving in 30 patients with Cushing\u2019s disease","volume":"19","author":"Geer","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.bcp.2024.116137_b0800","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm1201","article-title":"Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis","volume":"11","author":"Lam","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2024.116137_b0805","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma Ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b0810","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","article-title":"Inhibition of food intake in obese subjects by peptide YY 3\u201336","volume":"349","author":"Batterham","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116137_b0815","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/j.gastro.2005.09.001","article-title":"Effect of peptide YY3\u201336 on food intake in humans","volume":"129","author":"Degen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2024.116137_b0820","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2004.02169.x","article-title":"Ghrelin and adiponectin in patients with Cushing\u2019s disease before and after successful transsphenoidal surgery","volume":"62","author":"Lib\u00e8","year":"2005","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0825","doi-asserted-by":"crossref","unstructured":"Otto, B., Tschop, M., Heldwein, W., Pfeiffer, A. F. H. & Diederich, S. Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur. J. Endocrinol. (2004).","DOI":"10.1530\/eje.0.1510113"},{"key":"10.1016\/j.bcp.2024.116137_b0830","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MED.0000000000000184","article-title":"Leptin applications in 2015: what have we learned about leptin and obesity?","volume":"22","author":"Farr","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.bcp.2024.116137_b0835","doi-asserted-by":"crossref","first-page":"15958","DOI":"10.1074\/jbc.270.27.15958","article-title":"Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake","volume":"270","author":"De Vos","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116137_b0840","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/377527a0","article-title":"Transient increase in obese gene expression after food intake or insulin administration","volume":"377","author":"Saladin","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116137_b0845","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000330416","article-title":"Adipokines and Cardiovascular risk in Cushing\u2019s syndrome","volume":"95","author":"Valassi","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0850","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1152\/ajpendo.1999.277.4.E708","article-title":"Glucocorticoids reverse leptin effects on food intake and body fat in mice without increasing NPY mRNA","volume":"277","author":"Solano","year":"1999","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0855","doi-asserted-by":"crossref","first-page":"13670","DOI":"10.1073\/pnas.1901795116","article-title":"Leptin\u2019s hunger-suppressing effects are mediated by the hypothalamic\u2013pituitary\u2013adrenocortical axis in rodents","volume":"116","author":"Perry","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116137_b0860","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/DMSO.S182406","article-title":"Leptin resistance: underlying mechanisms and diagnosis","volume":"12","author":"Gruzdeva","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.bcp.2024.116137_b0865","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0306-4530(00)00035-4","article-title":"Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior","volume":"26","author":"Epel","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0870","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1507\/endocrj.K10E-370","article-title":"Corticotropin-releasing hormone (CRH) transgenic mice display hyperphagia with increased agouti-related protein mRNA in the hypothalamic arcuate nucleus","volume":"58","author":"Nakayama","year":"2011","journal-title":"Endocr. J."},{"key":"10.1016\/j.bcp.2024.116137_b0875","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","article-title":"Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism","volume":"23","author":"Di","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2024.116137_b0880","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism","volume":"1","author":"Kahn","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0885","doi-asserted-by":"crossref","unstructured":"Harno, E., Gali Ramamoorthy, T., Coll, A. P. & White, A. POMC: The Physiological Power of Hormone Processing. Physiol. Rev. 98, 2381\u20132430 (2018).","DOI":"10.1152\/physrev.00024.2017"},{"key":"10.1016\/j.bcp.2024.116137_b0890","first-page":"4272","article-title":"High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors","volume":"81","author":"Raffin-Sanson","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0895","doi-asserted-by":"crossref","first-page":"E1838","DOI":"10.1210\/jc.2014-1448","article-title":"Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome","volume":"99","author":"Page-Wilson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0900","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2007.02774.x","article-title":"Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing\u2019s disease from metabolic syndrome","author":"Setola","year":"2007","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b0905","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory Marker increases after long-term cure of Cushing\u2019s syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0910","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b0915","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0022-2275(20)32429-9","article-title":"Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects","volume":"40","author":"Large","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116137_b0920","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b0925","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b0930","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2018-02552","article-title":"Active Cushing disease is Characterized by increased adipose tissue macrophage presence","volume":"104","author":"Lee","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b0935","doi-asserted-by":"crossref","first-page":"e31274","DOI":"10.1371\/journal.pone.0031274","article-title":"TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages","volume":"7","author":"Bourlier","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2024.116137_b0940","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1210\/me.2008-0183","article-title":"Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes","volume":"23","author":"Keophiphath","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0945","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1210\/en.2006-0687","article-title":"Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes","volume":"148","author":"Lacasa","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b0950","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/21623945.2019.1690834","article-title":"Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of patients with cortisol-producing adenoma","volume":"8","author":"Wu","year":"2019","journal-title":"Adipocyte"},{"key":"10.1016\/j.bcp.2024.116137_b0955","doi-asserted-by":"crossref","unstructured":"Funder, J. W., Pearce, P. T., Smith, R. & Smith, A. I. Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated. Science 242, 583\u2013585 (1988).","DOI":"10.1126\/science.2845584"},{"key":"10.1016\/j.bcp.2024.116137_b0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/614074","article-title":"Adipose tissue and adrenal glands: novel pathophysiological mechanisms and clinical applications","volume":"2014","author":"Kargi","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0965","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.steroids.2014.05.001","article-title":"Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome","volume":"91","author":"Marzolla","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.bcp.2024.116137_b0970","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1677\/JOE-09-0292","article-title":"The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses","volume":"204","author":"Hoppmann","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0975","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1194\/jlr.M067728","article-title":"Low expression of the GILZ may contribute to adipose inflammation and altered adipokine production in human obesity","volume":"57","author":"Lee","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116137_b0980","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.mad.2004.06.010","article-title":"Mechanisms of glucocorticoid receptor signaling during inflammation","volume":"125","author":"Smoak","year":"2004","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bcp.2024.116137_b0985","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bcp.2024.116137_b0990","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1490543","article-title":"Hepatic steatosis in Cushing\u2019s syndrome: a radiological assessment using computed tomography","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b0995","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2024.116137_b1000","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2024.116137_b1005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2265.2006.02466.x","article-title":"Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2006","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b1010","unstructured":"Feingold, K. R. Introduction to Lipids and Lipoproteins. in Endotext (eds. Feingold, K. R. et al.) (MDText.com, Inc., South Dartmouth (MA), 2000)."},{"key":"10.1016\/j.bcp.2024.116137_b1015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2007.05.015","article-title":"Glucocorticoids, metabolism and metabolic diseases","volume":"275","author":"Vegiopoulos","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1020","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2337\/db12-1208","article-title":"Dietary proteins contribute little to glucose production, even under optimal gluconeogenic conditions in healthy humans","volume":"62","author":"Fromentin","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b1025","first-page":"45","article-title":"Metabolic effects of glucagon in humans","volume":"15","author":"Adeva-Andany","year":"2019","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1030","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.metabol.2011.06.012","article-title":"The effects of glucocorticoids on adipose tissue lipid metabolism","volume":"60","author":"Peckett","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2024.116137_b1035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.biochem.66.1.581","article-title":"Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression","volume":"66","author":"Hanson","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2024.116137_b1040","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fendo.2018.00802","article-title":"Unraveling the regulation of hepatic gluconeogenesis","volume":"9","author":"Zhang","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2337\/diabetes.49.6.896","article-title":"5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase","volume":"49","author":"Lochhead","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b1050","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/me.2014-1062","article-title":"Minireview: new Molecular mediators of glucocorticoid receptor activity in metabolic tissues","volume":"28","author":"Patel","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1055","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1172\/JCI66062","article-title":"Dexamethasone-induced kr\u00fcppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia","volume":"129","author":"Cui","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1060","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1172\/JCI128481","article-title":"Taking KLF9 to \u201cCort\u201d for crimes against metabolism","volume":"129","author":"Sweet","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1065","doi-asserted-by":"crossref","first-page":"e93531","DOI":"10.1371\/journal.pone.0093531","article-title":"Pancreatic alpha-cell dysfunction contributes to the disruption of glucose homeostasis and compensatory insulin Hypersecretion in glucocorticoid-treated rats","volume":"9","author":"Rafacho","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2024.116137_b1070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fphys.2019.00413","article-title":"Glucagon receptor signaling and lipid metabolism","volume":"10","author":"Galsgaard","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2024.116137_b1075","doi-asserted-by":"crossref","unstructured":"Kuo, T., McQueen, A., Chen, T.-C. & Wang, J.-C. Regulation of Glucose Homeostasis by Glucocorticoids. in Glucocorticoid Signaling: From Molecules to Mice to Man (eds. Wang, J.-C. & Harris, C.) 99\u2013126 (Springer, New York, NY, 2015). doi: 10.1007\/978-1-4939-2895-8_5.","DOI":"10.1007\/978-1-4939-2895-8_5"},{"key":"10.1016\/j.bcp.2024.116137_b1080","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1085","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1079\/BJN\/2002544","article-title":"Dietary carbohydrate\u2019s effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations","volume":"87","author":"Parks","year":"2002","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bcp.2024.116137_b1090","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s00125-009-1405-9","article-title":"Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes","volume":"52","author":"Wilke","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2024.116137_b1095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","article-title":"Resolving the Paradox of hepatic insulin resistance","volume":"7","author":"Santoleri","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2024.116137_b1105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferr\u00e9","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tem.2013.01.003","article-title":"Novel insights into ChREBP regulation and function","volume":"24","author":"Filhoulaud","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1115","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-006-0295-3","article-title":"Signalling mechanisms linking hepatic glucose and lipid metabolism","volume":"49","author":"Weickert","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2024.116137_b1120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1507\/endocrj.K09E-298","article-title":"Hormonal regulation of acetyl-CoA Carboxylase isoenzyme gene transcription","volume":"57","author":"Zhao","year":"2010","journal-title":"Endocr. J."},{"key":"10.1016\/j.bcp.2024.116137_b1125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0003-9861(51)90225-1","article-title":"The synergistic effect of cortisone and insulin on lipogenesis in the perfused rat liver as studied with \u03b1-C14-acetate","volume":"31","author":"Altman","year":"1951","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2024.116137_b1130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-3701-2-19","article-title":"Regulation of triglyceride metabolism by glucocorticoid receptor","volume":"2","author":"Wang","year":"2012","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bcp.2024.116137_b1135","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1432-1033.1975.tb04097.x","article-title":"Modulation of the activity of insulin-dependent enzymes of lipogenesis by glucocorticoids","volume":"53","author":"Diamant","year":"1975","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2024.116137_b1140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/bj2120135","article-title":"The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes","volume":"212","author":"Amatruda","year":"1983","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116137_b1145","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2147\/DMSO.S212715","article-title":"SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions","volume":"12","author":"Gharaibeh","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.bcp.2024.116137_b1150","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S2213-8587(13)70170-0","article-title":"Inhibition of 11\u03b2-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2","author":"Stefan","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1155","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1194\/jlr.R800085-JLR200","article-title":"Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways","volume":"50","author":"Goldberg","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116137_b1160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1165","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1172\/JCI115206","article-title":"Measurement of de novo hepatic lipogenesis in humans using stable isotopes","volume":"87","author":"Hellerstein","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ajcn\/81.1.35","article-title":"Temporal pattern of de novo lipogenesis in the postprandial state in healthy men1\u20133","volume":"81","author":"Timlin","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bcp.2024.116137_b1175","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1172\/JCI6572","article-title":"Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance","volume":"104","author":"Parks","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1180","doi-asserted-by":"crossref","unstructured":"Alves\u2010Bezerra, M. & Cohen, D. E. Triglyceride Metabolism in the Liver. in Comprehensive Physiology (ed. Terjung, R.) 1\u201322 (Wiley, 2017). doi:10.1002\/cphy.c170012.","DOI":"10.1002\/cphy.c170012"},{"key":"10.1016\/j.bcp.2024.116137_b1185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1079\/PNS2004331","article-title":"Regulation of fatty acid transport by fatty acid translocase\/CD36","volume":"63","author":"Bonen","year":"2004","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.bcp.2024.116137_b1190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.plefa.2010.02.029","article-title":"Fatty acid transport across the cell membrane: regulation by fatty acid transporters","volume":"82","author":"Schwenk","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids PLEFA"},{"key":"10.1016\/j.bcp.2024.116137_b1195","doi-asserted-by":"crossref","first-page":"G850","DOI":"10.1152\/ajpgi.00378.2011","article-title":"Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids","volume":"302","author":"D\u2019souza","year":"2012","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2024.116137_b1200","doi-asserted-by":"crossref","first-page":"G1141","DOI":"10.1152\/ajpgi.1997.272.5.G1141","article-title":"Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation","volume":"272","author":"Letteron","year":"1997","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2024.116137_b1205","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1\u03b1 deficiency causes multi-system energy metabolic Derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bcp.2024.116137_b1210","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","article-title":"The coactivator PGC-1 cooperates with Peroxisome proliferator-activated receptor \u03b1 in transcriptional control of Nuclear genes encoding mitochondrial fatty acid oxidation enzymes","volume":"20","author":"Vega","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2024.116137_b1215","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/JOE-14-0373","article-title":"Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes","volume":"223","author":"Rafacho","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1220","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/bj3380569","article-title":"Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis","volume":"338","author":"Hegardt","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116137_b1225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrm2327","article-title":"Molecular and metabolic mechanisms of insulin resistance and \u03b2-cell failure in type 2 diabetes","volume":"9","author":"Muoio","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116137_b1230","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.ATV.15.9.1481","article-title":"Effects of dexamethasone on the synthesis, degradation, and secretion of apolipoprotein B in cultured rat hepatocytes","volume":"15","author":"Wang","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2024.116137_b1235","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/bj20031320","article-title":"Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone","volume":"378","author":"Dolinsky","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116137_b1240","first-page":"770","article-title":"Hepatic ABCA1 and VLDL triglyceride production","author":"Liu","year":"1821","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bcp.2024.116137_b1245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-2275(20)36835-8","article-title":"Ultrastructural and physiological evidence for corticosteroid-induced alterations in hepatic production of very low density lipoprotein particles","volume":"15","author":"Reaven","year":"1974","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116137_b1250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-2275(20)38176-1","article-title":"Effects of adrenalectomy and dexamethasone on hepatic lipid metabolism","volume":"23","author":"Cole","year":"1982","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116137_b1255","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ncpcardio0319","article-title":"Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart","volume":"2","author":"Iacobellis","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2024.116137_b1260","doi-asserted-by":"crossref","unstructured":"Gaborit, B., Sengenes, C., Ancel, P., Jacquier, A. & Dutour, A. Role of Epicardial Adipose Tissue in Health and Disease: A Matter of Fat? in Comprehensive Physiology (ed. Terjung, R.) 1051\u20131082 (Wiley, 2017). doi: 10.1002\/cphy.c160034.","DOI":"10.1002\/cphy.c160034"},{"key":"10.1016\/j.bcp.2024.116137_b1265","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.jacc.2018.07.096","article-title":"Cushing syndrome is associated with subclinical LV dysfunction and increased Epicardial adipose tissue","volume":"72","author":"Maurice","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2024.116137_b1270","article-title":"Epicardial and Pericardial adiposity without Myocardial steatosis in Cushing syndrome","volume":"dgab556","author":"Wolf","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1275","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12933-015-0289-x","article-title":"Impact of long-term steroid therapy on epicardial and pericardial fat deposition: a cardiac MRI study","volume":"14","author":"Kitterer","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcp.2024.116137_b1280","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ijo.2011.117","article-title":"Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat","volume":"36","author":"Gaborit","year":"2012","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bcp.2024.116137_b1285","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijcard.2006.04.016","article-title":"Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects","volume":"115","author":"Iacobellis","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bcp.2024.116137_b1290","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s00380-015-0650-8","article-title":"Relationship between epicardial adipose tissue thickness and early impairment of left ventricular systolic function in patients with preserved ejection fraction","volume":"31","author":"Watanabe","year":"2016","journal-title":"Heart Vessels"},{"key":"10.1016\/j.bcp.2024.116137_b1295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/EJE-11-0601","article-title":"Increased myocardial fibrosis and left ventricular dysfunction in Cushing\u2019s syndrome","volume":"166","author":"Yiu","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1300","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the Myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2024.116137_b1305","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/cells11060991","article-title":"Browning Epicardial adipose tissue: friend or foe?","volume":"11","author":"Doukbi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2024.116137_b1310","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/MED.0000000000000077","article-title":"Advances in the assessment of cortisol exposure and sensitivity","volume":"21","author":"Wester","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.bcp.2024.116137_b1315","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.psyneuen.2015.08.014","article-title":"Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: a systematic review","volume":"62","author":"Incollingo Rodriguez","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b1320","doi-asserted-by":"crossref","first-page":"e0166842","DOI":"10.1371\/journal.pone.0166842","article-title":"In obesity, HPA Axis activity does not increase with BMI, but declines with aging: a meta-analysis of clinical studies","volume":"11","author":"Tenk","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bcp.2024.116137_b1325","series-title":"Tissue-specific Cushing\u2019s syndrome, 11b-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action","author":"Stewart","year":"2003"},{"key":"10.1016\/j.bcp.2024.116137_b1330","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/jc.2003-030440","article-title":"Association of 24-hour Cortisol production rates, Cortisol-binding globulin, and plasma-free Cortisol levels with body composition, leptin levels, and aging in adult men and women","volume":"89","author":"Purnell","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1335","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","article-title":"Tissue-specific dysregulation of Cortisol metabolism in human obesity","volume":"86","author":"Rask","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1340","first-page":"3330","article-title":"Tissue-specific changes in peripheral Cortisol metabolism in obese women: increased adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 activity","volume":"87","author":"Rask","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1345","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/0026-0495(92)90171-6","article-title":"Cortisol secretion in relation to body fat distribution in obese premenopausal women","volume":"41","author":"M\u00e5rin","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2024.116137_b1350","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1355","doi-asserted-by":"crossref","first-page":"183","DOI":"10.25011\/cim.v30i5.2894","article-title":"Measurement of cortisol in human hair as a biomarker of systemic exposure","volume":"30","author":"Sauv\u00e9","year":"2007","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.bcp.2024.116137_b1360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/FTD.0000000000000148","article-title":"Toward Standardization of hair Cortisol measurement: results of the first international interlaboratory round Robin","volume":"37","author":"Russell","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.bcp.2024.116137_b1365","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/oby.20795","article-title":"Long-term cortisol levels measured in scalp hair of obese patients","volume":"22","author":"Wester","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.bcp.2024.116137_b1370","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.biopsycho.2012.03.010","article-title":"Cortisol in hair, body mass index and stress-related measures","volume":"90","author":"Stalder","year":"2012","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.bcp.2024.116137_b1375","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/oby.21733","article-title":"Hair cortisol and adiposity in a population-based sample of 2,527 men and women aged 54 to 87 years","volume":"25","author":"Jackson","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.bcp.2024.116137_b1380","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/ijo.2016.113","article-title":"Long-term glucocorticoid concentrations as a risk factor for childhood obesity and adverse body-fat distribution","volume":"40","author":"Noppe","year":"2016","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bcp.2024.116137_b1385","first-page":"581","article-title":"Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications","author":"Chung","year":"1812","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"key":"10.1016\/j.bcp.2024.116137_b1390","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1002\/oby.20047","article-title":"Diurnal salivary cortisol is associated with body mass index and waist circumference: the multiethnic study of atherosclerosis: Neuroendocrine hormones and adiposity","volume":"21","author":"Champaneri","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.bcp.2024.116137_b1395","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/oby.2005.137","article-title":"Increased Cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women","volume":"13","author":"Duclos","year":"2005","journal-title":"Obes. Res."},{"key":"10.1016\/j.bcp.2024.116137_b1400","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF03343995","article-title":"Central and peripheral glucocorticoid receptor function in abdominal obesity","volume":"25","author":"Ljung","year":"2002","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1405","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.psyneuen.2005.02.003","article-title":"Modeling cortisol rhythms in a population-based study","volume":"30","author":"Ranjit","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b1410","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.psyneuen.2011.12.020","article-title":"Preliminary evidence for obesity and elevations in fasting insulin mediating associations between cortisol awakening response and hippocampal volumes and frontal atrophy","volume":"37","author":"Ursache","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bcp.2024.116137_b1415","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF03347017","article-title":"Rise in morning saliva cortisol is associated with abdominal obesity in men: a preliminary report","volume":"26","author":"Wallerius","year":"2003","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1420","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/sj.ijo.0802715","article-title":"Central adiposity and cortisol responses to waking in middle-aged men and women","volume":"28","author":"Steptoe","year":"2004","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bcp.2024.116137_b1425","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/oby.2007.509","article-title":"Awakening Cortisol response in lean, obese, and reduced obese individuals: effect of gender and fat Distribution*","volume":"15","author":"Therrien","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.bcp.2024.116137_b1430","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1210\/jc.2009-2105","article-title":"A Nonlinear relationship of generalized and central obesity with diurnal Cortisol secretion in the Whitehall II study","volume":"95","author":"Kumari","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1435","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004872-199602000-00012","article-title":"The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men","volume":"14","author":"Filipovsky","year":"1996","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2024.116137_b1440","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1210\/jcem.85.11.6946","article-title":"Abnormalities of the hypothalamic-Pituitary-adrenal Axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration","volume":"85","author":"Vicennati","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1445","first-page":"623","article-title":"Stress and body shape: stress-induced Cortisol secretion is consistently greater among women with central fat: psychosom","volume":"62","author":"Epel","year":"2000","journal-title":"Med."},{"key":"10.1016\/j.bcp.2024.116137_b1450","first-page":"1853","article-title":"Stress-related Cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities 1","volume":"83","author":"Rosmond","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1455","first-page":"341","article-title":"The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution","volume":"77","author":"Pasquali","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1460","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/diab.34.10.1055","article-title":"The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 Years of follow-up of the Participants in the study of men born in 1913","volume":"34","author":"Ohlson","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116137_b1465","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1002\/oby.20083","article-title":"Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature: Cortisol and metabolic syndrome","volume":"21","author":"Abraham","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.bcp.2024.116137_b1470","doi-asserted-by":"crossref","DOI":"10.14310\/horm.2002.1591","article-title":"Age and the metabolic syndrome affect salivary cortisol rhythm: data from a community sample","author":"Ceccato","year":"2015","journal-title":"HORMONES"},{"key":"10.1016\/j.bcp.2024.116137_b1475","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/j.1550-8528.1996.tb00546.x","article-title":"Inhibition of Cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study","volume":"4","author":"Ljung","year":"1996","journal-title":"Obes. Res."},{"key":"10.1016\/j.bcp.2024.116137_b1480","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40618-020-01197-6","article-title":"Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation","volume":"43","author":"Ceccato","year":"2020","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bcp.2024.116137_b1485","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1590\/S0004-27302007000800025","article-title":"Cushing\u2019s syndrome: aftermath of the cure","volume":"51","author":"Pivonello","year":"2007","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.bcp.2024.116137_b1490","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-012-0394-8","article-title":"Clinical consequences of Cushing\u2019s syndrome","volume":"15","author":"Valassi","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.bcp.2024.116137_b1495","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: the burden of Cushing\u2019s disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1500","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","article-title":"Metabolic, Cardiovascular, and Cerebrovascular outcomes in growth hormone-deficient subjects with previous Cushing\u2019s disease or non-functioning Pituitary adenoma","volume":"95","author":"Webb","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1505","first-page":"2747","article-title":"Plasma leptin levels do not change in patients with Cushing\u2019s disease shortly after correction of Hypercortisolism","volume":"82","author":"Cizza","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1510","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jc.2011-3123","article-title":"Body composition and Cardiovascular risk Markers after remission of Cushing\u2019s disease: a prospective study using whole-body MRI","volume":"97","author":"Geer","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116137_b1515","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2265.2010.03841.x","article-title":"The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the korean Sarcopenic obesity study (KSOS): visceral fat\/thigh muscle ratio and metabolic syndrome","volume":"73","author":"Lim","year":"2010","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.bcp.2024.116137_b1520","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.crad.2010.03.013","article-title":"Distribution of abdominal adipose tissue as a predictor of hepatic steatosis assessed by MRI","volume":"65","author":"Ducluzeau","year":"2010","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.bcp.2024.116137_b1525","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/0026-0495(94)90010-8","article-title":"Changes in body composition and adipose tissue distribution after treatment of women with Cushing\u2019s syndrome","volume":"43","author":"L\u00f6nn","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2024.116137_b1530","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/EJE-18-0318","article-title":"Active Cushing syndrome patients have increased ectopic fat deposition and bone marrow fat content compared to cured patients and healthy subjects: a pilot 1H-MRS study","volume":"179","author":"Maurice","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116137_b1535","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1359\/jbmr.061010","article-title":"Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-Year prospective study into young adulthood","volume":"22","author":"Leong","year":"2006","journal-title":"J. Bone Miner. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T20:23:32Z","timestamp":1728937412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":307,"alternative-id":["S0006295224001205"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116137","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipose tissue in cortisol excess: What Cushing\u2019s syndrome can teach us?","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116137"}}